intermune inc (IUX:Frankfurt)
As of 2:17 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - intermune inc (IUX)
| Name (Connections) | Board Relationships | Title | Key Developments |
| David Kabakoff Ph.D. | 48 Relationships | Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit & Compliance Committee and Member of Science Committee | InterMune Inc. announced delayed annual 10-K filing 03/15/07 |
| Louis Drapeau B.S., M.B.A. | 39 Relationships | Director, Chairman of Audit & Compliance Committee and Member of Compensation Committee | |
| Frank Verwiel M.D. | 10 Relationships | Director, Chairman of Compensation Committee and Member of Audit & Compliance Committee | |
| Angus Russell | 15 Relationships | Member of The Board of Directors and Member of Audit & Compliance Committee |
Nominating Committee* - intermune inc (IUX)
| Name (Connections) | Board Relationships | Title | Key Developments |
| David Kabakoff Ph.D. | 48 Relationships | Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit & Compliance Committee and Member of Science Committee | InterMune Inc. Appoints Sean P. Nolan as Executive Vice President and Chief Business Officer 02/14/13 |
| Lars Ekman M.D., Ph.D. | 54 Relationships | Lead Independent Director, Chairman of Science Committee and Member of Corporate Governance & Nominating Committee | Jonathan S. Leff Intends to Resign as a Member of the Board of Directors of InterMune Inc 11/30/12 |
| James Healy M.D., Ph.D. | 181 Relationships | Director, Member of Corporate Governance & Nominating Committee and Member of Science Committee | InterMune Inc. Announces Executive Changes, Effective June 8, 2012 04/26/12 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| IUX:GR | €7.63 EUR | -0.114 |  |
| Company | Last | Change |
| Amarillo Biosciences Inc | $0.02 USD | 0.00 |
| Biogen Idec Inc | $236.74 USD | +5.41 |
| Cell Therapeutics Inc | $1.27 USD | -0.05 |
| Hemispherx Biopharma Inc | $0.21 USD | +0.0072 |
| Roche Holding AG | SFr.258.50 CHF | +7.50 |
| View Industry Companies | ||
Industry Analysis
IUX
Industry Average
| Valuation | IUX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 24.7x |
|
| Price/Book | 5.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 3.9x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact INTERMUNE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
